Bioxcel Therap(BTAI.US)

Last Updated 19:00:00 ET
longbridge loading

Key facts: BTAI plans at-home IGALMI launch; Q4 adjusted loss $0.58

TradingView·
US
BTAI
+1.39%
US
XBI
+4.03%
US
SBIO
+3.67%
TradingView·
US
BTAI
+1.39%
US
XBI
+4.03%
US
SBIO
+3.67%

Earnings Scheduled For May 15, 2026

benzinga_article·
US
TRAW
+3.77%
US
INDP
-7.52%
US
MCB
+2.99%
benzinga_article·
US
TRAW
+3.77%
US
INDP
-7.52%
US
MCB
+2.99%

Bioxcel Therap | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 206 K

Earnings Watch·
US
BTAI
+1.39%
Earnings Watch·
US
BTAI
+1.39%

Bioxcel Therap | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 206 K

Earnings Watch·
US
BTAI
+1.39%
Earnings Watch·
US
BTAI
+1.39%

BTAI Q1'26 Earnings: EPS estimate is (0.53) USD

TradingView·
US
BTAI
+1.39%
TradingView·
US
BTAI
+1.39%

Biotalys Reports Full-Year 2025 Financial Results and Business Highlights

Unusual Whales·
US
BTAI
+1.39%
US
TBIO
0.00%
US
TLIS
0.00%
Unusual Whales·
US
BTAI
+1.39%
US
TBIO
0.00%
US
TLIS
0.00%

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc. | BBCMF Stock News

StockTitan·
US
LFCR
+3.54%
US
ATNF
0.00%
US
IBB
+2.19%
StockTitan·
US
LFCR
+3.54%
US
ATNF
0.00%
US
IBB
+2.19%

Bioxcel Issues Warrants in Private Equity Financing Deal

Tip Ranks·
US
BTAI
+1.39%
US
XBI
+4.03%
US
LABU
+12.11%
Tip Ranks·
US
BTAI
+1.39%
US
XBI
+4.03%
US
LABU
+12.11%

Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders? | AGL Stock News

StockTitan·
US
AGL
-7.66%
StockTitan·
US
AGL
-7.66%
© 2026 Longbridge｜Disclaimer